The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
You must have bought in around Dec 2019 then when it was getting a little difficult. I have just looked back my pf and 1st bought in here in November 2014. That is a long, time ago. (think it was on the back of the Xcite mess).
good point re Walbrook. They messed up my Motif bio share; messed up Omega; also questionable here too. Hopeless when it comes to comms. A lesson in reviewing future AIM advisers - keep well away..
So, 3 CA NEDS V 2 Executives and an new interim Chairman who is Independent, (or not?).
Very intriguing !
He took the previous 2 companies out of share ownership and into private ownership that is fact. We do not know if the shareholders benefitted, as it depended on what price was agreed. This could happen here in 12 months time too. Sell off, go private, or delist and do a management buy out. The key is the price?
Personally I'm waiting for a Director buy in to steady the ship. How many has Mr Leas bought??
When was he/she last on here. Definitely was all over this board most of 2020...?
So, far no one on here has discussed taking the company private. Remember, the new CFO is expert in doing this with last 2 companies he worked. Could they be pulling the SP to ground, to force a management buy out at peanuts?
Why is everyone on hear so keen to hear from the new CEO. Over at NCYT it took the new CEO 100 days from last october to january to talk to anyone. This could be same. Last year Omega's final year results to 31 March was not published until 13 July 21. So, might be a long wait for news. Any news.
That's not right. At the last investor call, the new CFO told us that the 2.5M was written down in the annual accounts, and was required to be paid back. He then told us he had approached the Bank for a 8M GBP loan arrangement which will assist with cash flow.
I am so upbeat here I feel relieved and quite happy this morning. Reading the update provided by CRA fund, I like daltry still cannot get my head around why our CEO is being so uncooperative. Whos interest is he benefiting? Kerogen?? It's beyond my understanding for sure. Surely after this years AGM in June, things will be brighter still..
are you referring to the Crystal Amber update which asks for new board member appointment? or do you have more intel?
Good post sense man but CRA has said in a dec RNS that it will no longer publish monthly NAV information and so we will no longer get these updated RNSS?
I thought the interims were good and the ammonia market is really exciting. Cooley is always neutral when asked about daily share price action. The recent raises were all oversubscribed, and there is plenty cash in the bank. I thought what he said was bang on, and straight regarding a period of delivery, and manufacturing capability. Plenty reasons to think this will reward by Q4 22, I think was mentioned.
52 week high. Didn't think I would see it over £25 this early in 2022.
Thanks for this. I am just so annoyed. Why publish this at half 6 on a Friday. It looks not normal practice. Come on RB.
Has Maris sneaked this out at half 6 after everyone has gone home for the week. Jeez. What timing and looks like a financial write down?
Plenty lateral flow tests in Berwick upon Tweed. Orient Gene ones at Boots this morning - pack of 7 - no queue.
I'm a bit concerned about the financial books looking back to the 1/2 yearly results too, so I have just been over the presentation again:
As of 30 september - Chris stated the following...
£4.7 M in bank
£0.5M cash burn per month
+£2M on the P&L sheet provided by DHSS
Consumed (£2.8M) in Global Health business incl COVID stock.
This looks bleak to me. They are overmanned, and underfunded and are running out of time, and money.
Perhaps worse off by not owning any IP.
Made a loss on COVID which is the reason a lot of PIs bought in back in 2020. Unbelievable really.
Last night CK confirmed that the 2M test capacity per week was 66% government equipment, and 33% ODX own capacity which means ODX have 330K per week currently for Health & Nutrition and Global Health divisions. Lets look at slide 17 for 6-months where they made £1.56M - It is clear that covid subcontracting for surescreen and pharmact make up 55% of this profit, but we dont know how many test contribute to the £863K - lets say its 0.50 per test so they may (optimistically) manufactured 2Million covid tests to round it up a bit. This isn't many, and therefore the numbers on this Financial slide look really poor. Really poor.
Going forwards, it is all about whether investors believe that the Global Health profitabilty can increase. I'm no longer sure of this, because it really feels like picking up scraps from Surescreen, Origene, and Pharmact to me.
The Health and Nutrition side of the business does look better, but that's not the reason the PIs piled in, is it?
I'm not so sure - we are well below the placing price of 42p - and they only have 5M cash. The MCAP is high, relative to shares in issue. I would suggest ABDX or NCYT a better bet.
That presentation was painful, and kind of comedy gold. I think CK actually said a lot, if not too much between 17:00 and 17:15 on antigen test, legal advice, companies named who walked away, and I am going to have to re-listen to that again. Almost too honest me thinks. I run out of patience overall and dialled off when the CFO came back on the line.
Just before lunch I bought another tranche - the 279, 678 rather than a straight 280k. Its gone through as a sell. Now I know a lot write about this "dark" stuff, but this is the first time it's happened to me.